Skip to main content
Ruchi Mathur, MD, Endocrinology, Los Angeles, CA

Ruchi Mathur MD FRCP(C)

Diabetes, Lipid Metabolism, Obesity, Thyroid


Director, Clinical Diabetes, Cedars-Sinai Medical Center; Director, Clinical Research and Operations, Medically Associated Science and Technology (MAST) Program, Cedars-Sinai Medical Center; Professor of Medicine, David Geffen School of Medicine at UCLA; Medical Director, Diabetes Outpatient Treatment and Education Center, Cedars-Sinai Medical Center; Founding Member, Gemelli Biotech

Join to view full profile
  • Cedars Sinai Medical CenterLos Angeles, CA 90048

  • Phone+1 310-423-0617

Dr. Mathur is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Board Certified Endocrinologist;
    Director, Clinical Diabetes, Cedars-Sinai;
    Director of Clinical Research and Operations Medically Associated Science and Technology (MAST) Program at Cedars-Sinai;
    Professor of Medicine, David Geffen School of Medicine at UCLA;
    Founding Member: Gemelli Biotech

Education & Training

  • Cedars-Sinai Medical Center
    Cedars-Sinai Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1999 - 2000
  • University of Manitoba
    University of ManitobaClass of 1992

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1996 - 2028

Awards, Honors, & Recognition

  • Covingtons Who’s Who in Medicine
  • Patient Choice Award American Registry
  • Top 10 Doctor Award American Registry, 2013-2021

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Declining Rates of Referral for Irritable Bowel Syndrome Without Constipation at a Tertiary Care Center  
    Nipaporn Pichetshote, Vartan C Tashjian, Mark Pimentel, Ali Rezaie, Ruchi Mathur, Digestive Diseases and Sciences
  • Ethnic Diverstiy in Susceptibility of Beta Cell Function to Pancreatic Triglyceride levels  
    Lingvay I, Mathur R, Szczpaniak E, Szczpaniak L, J Diabetes Metab, 1/1/2014
  • Methane-producing human subjects have higher serum glucose levels during oral glucose challenge than non-methane produers: A pilot study of enteric methanogens on glyc...  
    Mathur R, Goyal D, Kim G, Barlow GM, Chua KS, Pimentel M, Research Journal of Endocrinology and Metabolism, 1/1/2014

Books/Book Chapters

Abstracts/Posters

  • A large scale evaluation of the small intestinal microbiome in subjects on proton pump inhibitors
    Weitsman S, Leite G, Celly S, Morales W, Sanchez M, Parodi G, Villanueva-Millan MJ, Sedighi R, Chang C, Mathur R, Rezaie A, Pimentel M., Digestive Disease Week 2019, #979
  • Pattern of Hydrogen and Methane Production by Gut Microbiome in Non-Alcoholic Fatty Liver Disease (NAFLD): A Large-Scale Matched Case-Control Study.
    Pandyarajan V, Noureddin M, Pimentel Mark, Mathur R, Lin E, Chua KS, Solomon JS, Rezaie A., Digestive Disease Week 2018, #Tu 1518
  • The Non-Absorbable Antibiotic Rifaximin Exhibits Weight Neutrality in the Host
    Morales W, Leite G, Weitsman S, Celly S, Schultz H, Do H, Parodi G, Singer-Englar T, Barlow G, Pimentel M, Mathur R., Digestive Disease Week 2018, #Su1986

Lectures

  • Introduction to the small bowel microbiome 
    IX International GI Motility Course - Bogota, Columbia - 11/16/2019
  • Gastrointestinal Microbiome in Obesity and Diabetes 
    IX International GI Motility Course - Bogota Columbia - 11/15/2019
  • The role of Tech Transfer and Science 
    Cedars-Sinai Medical Center - 2/27/2019

Other

  • Requested Review of Kostic AD et al The Dynamics of Human Infant Gut Microbiome in the Development and Progression towardsType 1 Diabetes (cell Host Microbe 2015,17) 
    Mathur R, Endocrinology Today
    1/1/2015
  • Expert commentary on: "The lack of utility of circulating biomarkers of inflammation and endothelial dysfunction for type 2 diabetes risk prediction among post menopau... 
    Yuan P, Mathur R, North American Menopause Society, First to Know Series
    1/22/2010
  • Expert commentary on the Lack of circulating biomarkers for type 2 diabetes risk prediction in the WHI Observational Study. 
    Yuan P Mathur R, North American Menopause Society, First to Know Series
    1/11/2010

Press Mentions

  • Hypothyroidism Linked to Gut Microbiome Disturbances
    Hypothyroidism Linked to Gut Microbiome DisturbancesJuly 22nd, 2025
  • HMN 2025: How Thyroid Therapy Might Enhance Intestine Well Being in Individuals with Hypothyroidism
    HMN 2025: How Thyroid Therapy Might Enhance Intestine Well Being in Individuals with HypothyroidismJuly 12th, 2025
  • Thyroid Treatment May Improve Gut Health in People with Hypothyroidism
    Thyroid Treatment May Improve Gut Health in People with HypothyroidismJuly 8th, 2025

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: